Does RUXOLITINIB Cause Hypomagnesaemia? 19 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 19 reports of Hypomagnesaemia have been filed in association with RUXOLITINIB (OPZELURA). This represents 0.0% of all adverse event reports for RUXOLITINIB.
19
Reports of Hypomagnesaemia with RUXOLITINIB
0.0%
of all RUXOLITINIB reports
0
Deaths
16
Hospitalizations
How Dangerous Is Hypomagnesaemia From RUXOLITINIB?
Of the 19 reports, 16 (84.2%) required hospitalization, and 1 (5.3%) were considered life-threatening.
Is Hypomagnesaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RUXOLITINIB. However, 19 reports have been filed with the FAERS database.
What Other Side Effects Does RUXOLITINIB Cause?
Off label use (12,492)
Death (6,561)
Fatigue (5,663)
Anaemia (3,593)
Haemoglobin decreased (3,297)
Platelet count decreased (3,028)
Diarrhoea (2,531)
Asthenia (2,529)
Dizziness (2,398)
Pneumonia (2,343)
What Other Drugs Cause Hypomagnesaemia?
OMEPRAZOLE (1,766)
PANTOPRAZOLE (1,246)
PANITUMUMAB (611)
ESOMEPRAZOLE (591)
CARBOPLATIN (586)
LANSOPRAZOLE (504)
FUROSEMIDE (501)
FLUOROURACIL (477)
METFORMIN (415)
CISPLATIN (395)
Which RUXOLITINIB Alternatives Have Lower Hypomagnesaemia Risk?
RUXOLITINIB vs SABRIL
RUXOLITINIB vs SACCHAROMYCES CEREVISIAE
RUXOLITINIB vs SACITUZUMAB GOVITECAN
RUXOLITINIB vs SACITUZUMAB GOVITECAN-HZIY
RUXOLITINIB vs SACROSIDASE